Blueprint Medicines所有资讯

Blueprint Medicines | 4：持股变动声明-董事 COATS LONNEL

11/22 16:51 (美东)

Blueprint Medicines | SC 13G/A：超过5%持股股东披露文件(修正)-T. ROWE PRICE ASSOCIATES, INC.(8.5%)

11/14 13:29 (美东)

Blueprint Medicines | 4：持股变动声明-董事 Albers Jeffrey W.

11/12 16:21 (美东)

Blueprint Medicines | 4：持股变动声明-高管 Namouni Fouad

10/04 17:14 (美东)

Blueprint Medicines | 4：持股变动声明-董事 Albers Jeffrey W.

09/11 16:11 (美东)

Blueprint Medicines | 4：持股变动声明-高管 Landsittel Michael

08/19 16:03 (美东)

Blueprint Medicines | 4：持股变动声明-高管 Lee Philina

08/07 17:12 (美东)

Blueprint Medicines | 4：持股变动声明-高管 Carter Percy H.

07/08 19:13 (美东)

Blueprint Medicines | 4：持股变动声明-高管 Rossi Christina

07/08 19:13 (美东)

Blueprint Medicines | 4：持股变动声明-高管 Durso-Bumpus Debra

07/08 16:08 (美东)

Blueprint Medicines | 4：持股变动声明-高管 Durso-Bumpus Debra

07/02 16:10 (美东)

Blueprint Medicines | 4：持股变动声明-高管 Durso-Bumpus Debra

06/25 16:01 (美东)

Blueprint Medicines | 4：持股变动声明-董事 Albers Jeffrey W.

06/14 17:45 (美东)

Blueprint Medicines | 4：持股变动声明-董事 COATS LONNEL

06/14 17:40 (美东)

Blueprint Medicines | 4：持股变动声明-董事 Beckman Daniella

06/14 17:40 (美东)

Blueprint Medicines | 4：持股变动声明-董事 Tsai John

06/14 17:40 (美东)

Blueprint Medicines | 4：持股变动声明-董事 Seely Lynn

06/14 17:40 (美东)

Blueprint Medicines | 4：持股变动声明-董事 Lydon Nicholas

06/14 17:40 (美东)

Blueprint Medicines | 4：持股变动声明-董事 Goldberg Mark Alan

06/14 17:35 (美东)

Blueprint Medicines | 4：持股变动声明-董事 Borisy Alexis

06/14 17:35 (美东)